Log In
Print
BCIQ
Print
Print this Print this
 

ABT-639

  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionCalcium channel, voltage‐gated (Cav3.2, T‐type) blocker
Molecular Target Calcium channel
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat diabetic neuropathic pain
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today